Chang Gok Woo

Prof. Chang Gok Woo

Pathology, Chungbuk National University Hospital, Cheongju-si, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in European Journal of Cancer
Verified
Journal Article
Closed access
SPSook Ryun Park
Sook Ryun Park
YPYoung Soo Park
Young Soo Park
MRMin-Hee Ryu
Min-Hee Ryu
BRBaek-Yeol Ryoo
Baek-Yeol Ryoo
CWChang Gok Woo
Chang Gok Woo
YKYoon-Koo Kang
Yoon-Koo Kang

1 January 2025 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
SSSeung-Myoung Son
Seung-Myoung Son
CWChang Gok Woo
Chang Gok Woo
OLOk-Jun Lee
Ok-Jun Lee
SLSun Kyung Lee
Sun Kyung Lee
MCMinkwan Cho
Minkwan Cho
HHHye Sook Han
Hye Sook Han
Son SM, et al. J Gastric Cancer. 2024 Dec;25:e2. https://doi.org/10.5230/jgc.2025.25.e2

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JKJihyoun Kim
Jihyoun Kim
JKjun hyoung kim
jun hyoung kim
CWChang Gok Woo
Chang Gok Woo
Kim JH, et al. J Korean Med Sci. 2022 Mar;37(11):e91. https://doi.org/10.3346/jkms.2022.37.e91

15 July 2022 in Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
CWChang Gok Woo
Chang Gok Woo
SSSeung-Myoung Son
Seung-Myoung Son
HLHo-Chang Lee
Ho-Chang Lee
HHHye Sook Han
Hye Sook Han
KLKi Hyeong Lee
Ki Hyeong Lee
OLOk-Jun Lee
Ok-Jun Lee
PurposeHistologic change is a resistant mechanism in lung cancer. The most common histological change is the switch from adenocarcinoma (AdenoCa) to small cell carcinoma (SCC) against to tyrosine kinase inhibitors (TKI). However, it is not clear whether other treatment modalities are involved in the histologic changes.Materials and MethodsWe investigated histological changes in eight cases, after various treatments, and compared the molecular profiles between primary tumors and changed tumors using exome sequencing where tissue was available.ResultsThree cases of AdenoCa that were changed into SCC retained the initial mutations after TKI and/or surgical treatment. After treatment with TKI and immunotherapy, an EGFR (epidermal growth factor receptor)-mutant AdenoCa changed to squamous cell carcinoma (SqCa). SqCa in a patient treated with surgery was changed into combined AdenoCa and SqCa. These two cases showed the same genetic variations between the two distinct non–small cell carcinomas (NSCC). Three patients experienced two histologic changes, which the changed tumors returned to its original subtype or changed to a combined tumor after treatments. Four cases showed combined histology in the first or second change.ConclusionThe histology of NSCC can be changed to a single pattern or combined subtypes after various treatment modalities, and the phenotypic changes seem not fixed. Therefore, additional morphologic changes may occur regardless of their genetic status and types of treatments. To refine the new treatment strategy, consecutive repeated biopsies in progressive disease or recurrent tumor are necessary.

1 January 2020 in Yonsei Medical Journal
Verified
Journal Article
Open access
CWChang Gok Woo
Chang Gok Woo
SYSeok Joong Yun
Seok Joong Yun
SSSeung-Myoung Son
Seung-Myoung Son
YLYoung Hyun Lim
Young Hyun Lim
OLOk-Jun Lee
Ok-Jun Lee
The World Health Organization 2016 edition assigned anaplastic lymphoma kinase (ALK) rearrangement-associated renal cell carcinoma (ALK-RCC) as an emerging renal tumor entity. Identifying ALK-RCC is important because ALK inhibitors have been shown to be effective in treatment. Here, we report the case of a 14-year-old young man with ALK-RCC. Computed tomography revealed a well-demarcated 5.3-cm enhancing mass at the upper pole of the left kidney. There was no further history or symptoms of the sickle-cell trait. The patient underwent left radical nephrectomy. Pathologically, the mass was diagnosed as an unclassified RCC. Targeted next-generation sequencing identified a TPM3-ALK fusion gene. The present report and literature review demonstrate that TPM3-ALK RCC may be associated with distinct clinicopathological features. Microscopically, the tumors showed diffuse growth and tubulocystic changes with inflammatory cell infiltration. Tumor cells were dis-cohesive and epithelioid with abundant eosinophilic cytoplasm and cytoplasmic vacuoles. If morphological features and TFE3 expression are present in adolescent and young patients, molecular tests for ALK translocation should be performed. This awareness is critically important, because ALK rearrangement confers sensitivity to ALK inhibitors.

15 April 2022 in Medicine
Verified
Journal Article
Open access
HCHanlim Choi
Hanlim Choi
JCJae-Woon Choi
Jae-Woon Choi
DRDong Hee Ryu
Dong Hee Ryu
SPSungmin Park
Sungmin Park
MKMyung Jo Kim
Myung Jo Kim
CWChang Gok Woo
Chang Gok Woo
Rationale: Gangliocytic paraganglioma (GP) is a rare tumor that mostly develops in the duodenum and is composed of the following 3 cell types: epithelioid endocrine, spindle-like, and ganglion-like cells. It manifests as symptoms such as abdominal pain, gastrointestinal bleeding, and weight loss; however, occasionally, it is incidentally detected on endoscopic or radiologic examinations. Although GP is usually benign, it can metastasize to the lymph nodes, and distant metastases have been reported in some cases. Patient concerns: A 46-year-old woman presented with anemia on health surveillance examination. She had no other specific symptoms, and her physical examination did not reveal any abnormal finding. Diagnosis: Endoscopic ultrasound-guided fine-needle aspiration biopsy was performed, and the endoscopist obtained samples from the inner side of the ampullary mass. Pathological examination suggested GP or a neuroendocrine tumor. Interventions: Initially, we planned transduodenal ampullectomy with lymph node excision. However, there was severe fibrosis around the duodenum, and an examination of a frozen biopsy sample from the periduodenal lymph node showed atypical cells in the lymph node. Therefore, we performed pylorus-preserving pancreaticoduodenectomy with lymph node dissection. Outcomes: The final pathological diagnosis was GP located in the ampulla of Vater. The GP showed lymphovascular and perineural invasion and invaded the duodenal wall. Furthermore, 4 out of 18 harvested lymph nodes showed metastasis. Lessons: We described a case of GP confined to the ampulla with regional lymph node metastasis and reviewed published literature on ampullary GP with lymph node metastasis.